<p>In today's podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recorlev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing's Syndrome. While this podcast contains medical and technical terminology, we encourage patients to listen to it and discuss it with their physicians.</p>

In today's podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recorlev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing's Syndrome. While this podcast contains medical and technical terminology, we encourage patients to listen to it and discuss it with their physicians.

S8E2: Recorlev (Levoketoconazole)

Knowledge and information are critical tools to affect early diagnosis in pituitary disease.  Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.  Each episode brings conversations with information and experiences from expert professionals and people living with these challenging disorders.

Science

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions. Each episode brings conversations with information and experiences from expert professionals and people living with these challenging disorders.

Share S8E2: Recorlev (Levoketoconazole)

Sign up to save your podcasts

S8E2: Recorlev (Levoketoconazole)

S8E2: Recorlev (Levoketoconazole)

More shows like The Pituitary World News Podcast

The Curbsiders Internal Medicine Podcast

The Daily

Straight A Nursing: Study for nursing school exams & NCLEX

Core IM | Internal Medicine Podcast

Endocrine News Podcast

Annals On Call Podcast

The Health Wizard Podcast

Short History Of...

Ninja Nerd

Endocrine Feedback Loop